Clinical Trials Browser

Withdrawn × Interventional × aflutinib × Clear all

NCT04958967 2025-03-14

Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation

Phase 1 Withdrawn

NSCLC